Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment.
Identifieur interne : 000001 ( PubMed/Corpus ); précédent : 000000; suivant : 000002Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment.
Auteurs : Shawn D. Keil ; Izabela Ragan ; Susan Yonemura ; Lindsay Hartson ; Nicole K. Dart ; Richard BowenSource :
- Vox sanguinis [ 1423-0410 ] ; 2020.
Abstract
Severe acute respiratory distress syndrome coronavirus-2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is a member of the coronavirus family. Coronavirus infections in humans are typically associated with respiratory illnesses, however viral RNA has been isolated in serum from infected patients. Coronaviruses have been identified as a potential low-risk threat to blood safety. The Mirasol Pathogen Reduction Technology (PRT) System utilizes riboflavin and ultraviolet (UV) light to render blood-borne pathogens noninfectious, while maintaining blood product quality. Here we report on the efficacy of riboflavin and UV light against the pandemic virus SARS-CoV-2 when tested in both plasma and platelets units.
DOI: 10.1111/vox.12937
PubMed: 32311760
Links to Exploration step
pubmed:32311760Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment.</title><author><name sortKey="Keil, Shawn D" sort="Keil, Shawn D" uniqKey="Keil S" first="Shawn D" last="Keil">Shawn D. Keil</name><affiliation><nlm:affiliation>Terumo BCT, Lakewood, CO, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Ragan, Izabela" sort="Ragan, Izabela" uniqKey="Ragan I" first="Izabela" last="Ragan">Izabela Ragan</name><affiliation><nlm:affiliation>Colorado State University, Department of Biomedical Sciences, Fort Collins, CO, USA, Fort Collins.</nlm:affiliation></affiliation></author><author><name sortKey="Yonemura, Susan" sort="Yonemura, Susan" uniqKey="Yonemura S" first="Susan" last="Yonemura">Susan Yonemura</name><affiliation><nlm:affiliation>Terumo BCT, Lakewood, CO, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Hartson, Lindsay" sort="Hartson, Lindsay" uniqKey="Hartson L" first="Lindsay" last="Hartson">Lindsay Hartson</name><affiliation><nlm:affiliation>Colorado State University, Infectious Disease Research Center, Fort Collins, CO, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Dart, Nicole K" sort="Dart, Nicole K" uniqKey="Dart N" first="Nicole K" last="Dart">Nicole K. Dart</name><affiliation><nlm:affiliation>Terumo BCT, Lakewood, CO, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Bowen, Richard" sort="Bowen, Richard" uniqKey="Bowen R" first="Richard" last="Bowen">Richard Bowen</name><affiliation><nlm:affiliation>Colorado State University, Department of Biomedical Sciences, Fort Collins, CO, USA, Fort Collins.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32311760</idno><idno type="pmid">32311760</idno><idno type="doi">10.1111/vox.12937</idno><idno type="wicri:Area/PubMed/Corpus">000001</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000001</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment.</title><author><name sortKey="Keil, Shawn D" sort="Keil, Shawn D" uniqKey="Keil S" first="Shawn D" last="Keil">Shawn D. Keil</name><affiliation><nlm:affiliation>Terumo BCT, Lakewood, CO, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Ragan, Izabela" sort="Ragan, Izabela" uniqKey="Ragan I" first="Izabela" last="Ragan">Izabela Ragan</name><affiliation><nlm:affiliation>Colorado State University, Department of Biomedical Sciences, Fort Collins, CO, USA, Fort Collins.</nlm:affiliation></affiliation></author><author><name sortKey="Yonemura, Susan" sort="Yonemura, Susan" uniqKey="Yonemura S" first="Susan" last="Yonemura">Susan Yonemura</name><affiliation><nlm:affiliation>Terumo BCT, Lakewood, CO, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Hartson, Lindsay" sort="Hartson, Lindsay" uniqKey="Hartson L" first="Lindsay" last="Hartson">Lindsay Hartson</name><affiliation><nlm:affiliation>Colorado State University, Infectious Disease Research Center, Fort Collins, CO, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Dart, Nicole K" sort="Dart, Nicole K" uniqKey="Dart N" first="Nicole K" last="Dart">Nicole K. Dart</name><affiliation><nlm:affiliation>Terumo BCT, Lakewood, CO, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Bowen, Richard" sort="Bowen, Richard" uniqKey="Bowen R" first="Richard" last="Bowen">Richard Bowen</name><affiliation><nlm:affiliation>Colorado State University, Department of Biomedical Sciences, Fort Collins, CO, USA, Fort Collins.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Vox sanguinis</title><idno type="eISSN">1423-0410</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Severe acute respiratory distress syndrome coronavirus-2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is a member of the coronavirus family. Coronavirus infections in humans are typically associated with respiratory illnesses, however viral RNA has been isolated in serum from infected patients. Coronaviruses have been identified as a potential low-risk threat to blood safety. The Mirasol Pathogen Reduction Technology (PRT) System utilizes riboflavin and ultraviolet (UV) light to render blood-borne pathogens noninfectious, while maintaining blood product quality. Here we report on the efficacy of riboflavin and UV light against the pandemic virus SARS-CoV-2 when tested in both plasma and platelets units.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32311760</PMID><DateRevised><Year>2020</Year><Month>04</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1423-0410</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>Apr</Month><Day>20</Day></PubDate></JournalIssue><Title>Vox sanguinis</Title><ISOAbbreviation>Vox Sang.</ISOAbbreviation></Journal><ArticleTitle>Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/vox.12937</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVE" NlmCategory="OBJECTIVE">Severe acute respiratory distress syndrome coronavirus-2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is a member of the coronavirus family. Coronavirus infections in humans are typically associated with respiratory illnesses, however viral RNA has been isolated in serum from infected patients. Coronaviruses have been identified as a potential low-risk threat to blood safety. The Mirasol Pathogen Reduction Technology (PRT) System utilizes riboflavin and ultraviolet (UV) light to render blood-borne pathogens noninfectious, while maintaining blood product quality. Here we report on the efficacy of riboflavin and UV light against the pandemic virus SARS-CoV-2 when tested in both plasma and platelets units.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Stock SARS-CoV-2 was grown in Vero cells and inoculated into either plasma or platelet units. Those units were then treated with riboflavin and UV light. The infectious titers of SARS-CoV-2 were determined by plaque assay using Vero cells. A total of five (n=5) plasma and three (n=3) platelet products were evaluated in this study.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In both experiments the measured titer of SARS-CoV-2 was below the limit of detection following treatment with riboflavin and UV light. The mean log reductions in the viral titers were ≥3.40 and ≥4.53 for the plasma units and platelet units, respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Riboflavin and UV light effectively reduced the titer of SARS-CoV-2 in both plasma and platelet products to below the limit of detection in tissue culture. The data suggest that the process would be effective in reducing the theoretical risk of transfusion-transmitted SARS-CoV-2.</AbstractText><CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Keil</LastName><ForeName>Shawn D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Terumo BCT, Lakewood, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ragan</LastName><ForeName>Izabela</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Colorado State University, Department of Biomedical Sciences, Fort Collins, CO, USA, Fort Collins.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yonemura</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Terumo BCT, Lakewood, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartson</LastName><ForeName>Lindsay</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Colorado State University, Infectious Disease Research Center, Fort Collins, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dart</LastName><ForeName>Nicole K</ForeName><Initials>NK</Initials><AffiliationInfo><Affiliation>Terumo BCT, Lakewood, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowen</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Colorado State University, Department of Biomedical Sciences, Fort Collins, CO, USA, Fort Collins.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Vox Sang</MedlineTA><NlmUniqueID>0413606</NlmUniqueID><ISSNLinking>0042-9007</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">blood</Keyword><Keyword MajorTopicYN="N">pathogen reduction</Keyword><Keyword MajorTopicYN="N">riboflavin</Keyword><Keyword MajorTopicYN="N">ultraviolet</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32311760</ArticleId><ArticleId IdType="doi">10.1111/vox.12937</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000001 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000001 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:32311760
|texte= Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:32311760" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |